CIM
ATRC icon

Contravisory Investment Management’s AtriCure ATRC Stock Holding History

Contravisory Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,064
Closed -$222K – 364
2023
Q3 		$222K Buy
+5,064
New +$247K 0.06% 186

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Contravisory Investment Management's ATRC Position: Q4 2023 in Review

Contravisory Investment Management sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 5,064 shares — an estimated $222K sold.

Contravisory Investment Management first reported a position in ATRC in Q3 2023 and held it in 1 quarter. The position peaked at $222K in Q3 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Contravisory Investment Management reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 5,064 AtriCure shares in Q4 2023, an estimated $222K.
  • Contravisory Investment Management first reported a position in AtriCure in Q3 2023 and held it in 1 quarter.
  • Contravisory Investment Management's AtriCure position peaked at $222K in Q3 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Contravisory Investment Management's 13F filing for Q4 2023, filed 11 Jan 2024.